2022
DOI: 10.1016/j.envpol.2021.118390
|View full text |Cite
|
Sign up to set email alerts
|

Lycopene mitigates DEHP-induced hepatic mitochondrial quality control disorder via regulating SIRT1/PINK1/mitophagy axis and mitochondrial unfolded protein response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
31
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 62 publications
(33 citation statements)
references
References 83 publications
2
31
0
Order By: Relevance
“…The Pink1/Parkin pathway could govern mitochondrial quality control, mediating mitophagy to maintain mitochondrial fidelity. 26 The level of Pink1 was raised with ATZ exposure (Fig. 5H).…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…The Pink1/Parkin pathway could govern mitochondrial quality control, mediating mitophagy to maintain mitochondrial fidelity. 26 The level of Pink1 was raised with ATZ exposure (Fig. 5H).…”
Section: Discussionmentioning
confidence: 90%
“…The Pink1/Parkin pathway could mediate mitophagy in mammals, in response to mitochondrial quality control. 26 Parkin should be translocated into the impaired mitochondria to induce mitophagy. Thus, the level of Tom20 (a marker of the outer membrane of mitochondria) with Parkin overlapping was tested.…”
Section: Lyc Prevents Atz Exposure Induced Mitophagy Via Blocking Pin...mentioning
confidence: 99%
“…A large number of studies have shown that DEHP treatment can lead to mitochondrial damage. 53,56 In addition, LYC, as an antioxidant, has a good effect on alleviating mitochondrial damage. 57,58 These results are consistent with this experiment.…”
Section: Papermentioning
confidence: 99%
“…Mitophagy elevation might be a protective mechanism against oxidative stress-mediated ROS production through the SIRT1-PGC-1α axis (Liang et al, 2020 ; Zhao et al, 2022 ). This axis is also involved in C2C12 myotubes (Chang et al, 2021a ), cardiac dysfunction in doxorubicin-induced cardiomyopathy (Wang et al, 2021 ), and podocyte injury in diabetic nephropathy (Zhou et al, 2019 ).…”
Section: Methodsmentioning
confidence: 99%